Impact of eating probiotic yogurt on colonization by Candida species of the oral and vaginal mucosa in HIV-infected and HIV-uninfected women
- PMID: 23925786
- PMCID: PMC3903393
- DOI: 10.1007/s11046-013-9678-4
Impact of eating probiotic yogurt on colonization by Candida species of the oral and vaginal mucosa in HIV-infected and HIV-uninfected women
Abstract
Background: Candidiasis in HIV/AIDS patients continues to be a public health problem. Antifungal therapies are not always effective and may result in complications, such as the development of drug-resistant strains of Candida species.
Objectives: This study evaluated the impact of probiotic consumption on Candida colonization of the oral and vaginal mucosa.
Patients/methods: A pilot study was conducted in 24 women (17 HIV-infected, 7 HIV-uninfected) from the Women's Interagency HIV Study. The women underwent a 60-day initiation period with no probiotic consumption, followed by two 15-day consumption periods, with a different probiotic yogurt (DanActive™ or YoPlus™ yogurt) during each interval. There was a 30-day washout period between the two yogurt consumption periods. Oral and vaginal culture swabs were collected on days 0, 60, 74, and 120. Candida was detected by inoculating each swab in both Sabouraud's dextrose agar with or without chloramphenicol and CHROMagar.
Results: Less fungal colonization among women was observed when the women consumed probiotic yogurts (54 % of the women had vaginal fungal colonization during the non-probiotic yogurt consumption period, 29 % during the DanActive™ period, and 38 % during YoPlus™ yogurt consumption period), and HIV-infected women had significantly lower vaginal fungal colonization after they consumed DanActive™ yogurt compared to the non-intervention periods (54 vs 29 %, p = 0.03).
Conclusions: These data are promising, but as expected in a small pilot study, there were some significant changes but also some areas where colonization was not changed. This type of conflicting data is supportive of the need for a larger trial to further elucidate the role of probiotic yogurts in fungal growth in HIV-infected women.
Conflict of interest statement
Figures
Similar articles
-
Colonization by Candida species of the oral and vaginal mucosa in HIV-infected and noninfected women.AIDS Res Hum Retroviruses. 2013 Jan;29(1):30-4. doi: 10.1089/AID.2012.0269. Epub 2012 Nov 19. AIDS Res Hum Retroviruses. 2013. PMID: 23098053 Free PMC article.
-
Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.J Clin Gastroenterol. 2012 Oct;46 Suppl:S73-80. doi: 10.1097/MCG.0b013e3182684d71. J Clin Gastroenterol. 2012. PMID: 22955364
-
Candida species isolated from the vaginal mucosa of HIV-infected women in Salvador, Bahia, Brazil.Braz J Infect Dis. 2011 May-Jun;15(3):239-44. doi: 10.1016/s1413-8670(11)70182-9. Braz J Infect Dis. 2011. PMID: 21670924
-
Oropharyngeal Candida colonization in human immunodeficiency virus infected patients.APMIS. 2013 May;121(5):375-402. doi: 10.1111/apm.12006. Epub 2012 Sep 25. APMIS. 2013. PMID: 23030258 Review.
-
The potential role for probiotic yogurt for people living with HIV/AIDS.Gut Microbes. 2010 Nov-Dec;1(6):411-4. doi: 10.4161/gmic.1.6.14079. Gut Microbes. 2010. PMID: 21468226 Free PMC article. Review.
Cited by
-
Vaginal prevention of Candida albicans: synergistic effect of lactobacilli and mannan oligosaccharides (MOS).Appl Microbiol Biotechnol. 2024 Dec;108(1):73. doi: 10.1007/s00253-023-12909-2. Epub 2024 Jan 9. Appl Microbiol Biotechnol. 2024. PMID: 38194142 Free PMC article.
-
Healthy Diet and Lifestyle Improve the Gut Microbiota and Help Combat Fungal Infection.Microorganisms. 2023 Jun 11;11(6):1556. doi: 10.3390/microorganisms11061556. Microorganisms. 2023. PMID: 37375058 Free PMC article. Review.
-
The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.FEMS Microbiol Rev. 2021 May 5;45(3):fuaa060. doi: 10.1093/femsre/fuaa060. FEMS Microbiol Rev. 2021. PMID: 33232448 Free PMC article. Review.
-
Development of Probiotic Formulations for Oral Candidiasis Prevention: Gellan Gum as a Carrier To Deliver Lactobacillus paracasei 28.4.Antimicrob Agents Chemother. 2020 May 21;64(6):e02323-19. doi: 10.1128/AAC.02323-19. Print 2020 May 21. Antimicrob Agents Chemother. 2020. PMID: 32253208 Free PMC article.
-
An Overview on Conventional and Non-Conventional Therapeutic Approaches for the Treatment of Candidiasis and Underlying Resistance Mechanisms in Clinical Strains.J Fungi (Basel). 2020 Feb 10;6(1):23. doi: 10.3390/jof6010023. J Fungi (Basel). 2020. PMID: 32050673 Free PMC article. Review.
References
-
- Ohmit SE, Sobel JD, Schuman P, Duerr A, Mayer K, Rompalo A, et al. Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis. 2003;188(1):118–27. doi: 10.1086/375746. - DOI - PubMed
-
- Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis. 2000;27(4):230–5. - PubMed
-
- Hauman CH, Thompson IO, Theunissen F, Wolfaardt P. Oral carriage of Candida in healthy and HIV-seropositive persons. Oral Surg Oral Med Oral Pathol. 1993;76(5):570–2. - PubMed
-
- Samaranayake LP. Oral mycoses in HIV infection. Oral Surg Oral Med Oral Pathol. 1992;73(2):171–80. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 AI 31834/AI/NIAID NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- U01-AI-34994/AI/NIAID NIH HHS/United States
- U01-AI-35004/AI/NIAID NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- U01-AI-34993/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- U01-AI-42590/AI/NIAID NIH HHS/United States
- U01 HD 32632/HD/NICHD NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- 3U01AI034994-17S1R/AI/NIAID NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- U01-AI-34989/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical